| 450K | Illumina 450K DNA methylation array |
| ADT | Androgen deprivation therapy |
| AN | Adjacent normal |
| AUC | Area under the curve |
| BCR | Biochemical recurrence |
| BPH | Benign prostatic hyperplasia |
| cfDNA | Cell-free DNA |
| CI | Confidence interval |
| CT | Cycle threshold |
| cT | Clinical T-stage |
| ctDNA | Circulating tumor DNA |
| DRE | Digital rectal examination |
| FFPE | Formalin-fixed paraffin embedded |
| HR | Hazard ratio |
| GS | Gleason Score |
| n | Number |
| N | N-stage |
| PBC | Peripheral blood cells |
| PCa | Prostate cancer |
| PSA | Prostate specific antigen |
| pT | Pathological T-stage |
| qMSP | Quantitative methylation specific PCR |
| qPCR | Quantitative PCR |
| RNAseq | RNA sequencing |
| ROC | Receiver operating characteristics |
| RP | Radical prostatectomy |
| RT | Radiotherapy |
| SM | Surgical margin |
| T-stage | Tumor stage |
| TCGA | The Cancer Genome Atlas |
| TRUS | Trans-rectal ultrasound |
| TURP | Transurethral resection of the prostate |
| WGA | Whole-genome amplified DNA |